PIA
BHVN

Piedmont Investment Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Piedmont Investment Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-475
Closed -$19K – 3007
2018
Q2 		$19K Buy
+475
New +$15.1K ﹤0.01% 1610

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Piedmont Investment Advisors's BHVN Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2018, closing a stake of 475 shares — an estimated $19K sold.

Piedmont Investment Advisors first reported a position in BHVN in Q2 2018 and held it in 1 quarter. The position peaked at $19K in Q2 2018. 119 funds tracked by Wall St. Rank hold BHVN as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 475 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2018, an estimated $19K.
  • Piedmont Investment Advisors first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $19K in Q2 2018.
  • 119 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.